Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Daniele Focosi and Massimo Franchini.
Daniele Focosi
Connection Strength
5.157
Massimo Franchini
  1. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert Rev Vaccines. 2021 May 27; 1-8.
    View in: PubMed
    Score: 0.948
  2. Clinical predictors of SARS-CoV-2 neutralizing antibody titers in COVID-19 convalescents: Implications for convalescent plasma donor recruitment. Eur J Haematol. 2021 Jul; 107(1):24-28.
    View in: PubMed
    Score: 0.941
  3. COVID-19 convalescent plasma therapy: hit fast, hit hard! Vox Sang. 2021 10; 116(9):935-942.
    View in: PubMed
    Score: 0.938
  4. The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19. Life (Basel). 2021 Feb 15; 11(2).
    View in: PubMed
    Score: 0.930
  5. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review. Transfus Apher Sci. 2021 Jun; 60(3):103071.
    View in: PubMed
    Score: 0.926
  6. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
    View in: PubMed
    Score: 0.240
  7. Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor-recipient differences in concentration of neutralizing antibodies. Clin Microbiol Infect. 2021 Jul; 27(7):987-992.
    View in: PubMed
    Score: 0.235
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.